Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology / Edition 1

Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology / Edition 1

ISBN-10:
3540794778
ISBN-13:
9783540794776
Pub. Date:
08/20/2008
Publisher:
Springer Berlin Heidelberg
ISBN-10:
3540794778
ISBN-13:
9783540794776
Pub. Date:
08/20/2008
Publisher:
Springer Berlin Heidelberg
Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology / Edition 1

Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology / Edition 1

Hardcover

$169.99
Current price is , Original price is $169.99. You
$169.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

In 1920s, Otto Warburg described the phenomenon of ‘aerobic glycolysis’, the ability of tumour cells to convert glucose to lactate in the presence of normal oxygen conditions. Warburg’s hypothesis of an altered metabolism in cancer cells found no immediate acceptance, though it was latter confirmed for most human tumours. With the advent of molecular biology the focus in tumour research has shifted towards the search for oncogenes. However, the interest in cancer molecular profiling eventually led to a renaissance of the Warburg effect trying to combine genetic alterations with effects on metabolism with the help of modern analytic technologies to rapidly analyze broad varieties of metabolites in various tissues and bodyfluids (metabonomics).


Product Details

ISBN-13: 9783540794776
Publisher: Springer Berlin Heidelberg
Publication date: 08/20/2008
Series: Ernst Schering Foundation Symposium Proceedings , #2007
Edition description: 2008
Pages: 265
Product dimensions: 5.90(w) x 8.40(h) x 0.60(d)

Table of Contents

Mihondria and Cancer.- Role of the Metabolic Stress Responses of Apoptosis and Autophagy in Tumor Suppression.- The Interplay Between MYC and HIF in the Warburg Effect.- Using Metabolomics to Monitor Anticancer Drugs.- Biomarker Discovery for Drug Development and Translational Medicine Using Metabonomics.- Pyruvate Kinase Type M2: A Key Regulator Within the Tumour Metabolome and a Tool for Metabolic Profiling of Tumours.- Molecular Imaging of Tumor Metabolism and Apoptosis.- Minimally Invasive Biomarkers for Therapy Monitoring.- Use of Metabolic Pathway Flux Information in Anticancer Drug Design.- Cancer Diagnostics Using 1H-NMR-Based Metabonomics.- Human Metabolic Phenotyping and Metabolome Wide Association Studies.- Defining Personal Nutrition and Metabolic Health Through Metabonomics.
From the B&N Reads Blog

Customer Reviews